Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» psoriasis
psoriasis
Coffee talk: Sun brings Ilumya patient stories to light with informal diner meetups
Fierce Pharma
Mon, 08/23/21 - 11:12 am
Sun Pharma
psoriasis
patients
DTC ads
Ilumya
Next-gen psoriasis drug rivalry between Bristol Myers and Nimbus spills into a legal battle
Endpoints
Tue, 08/17/21 - 10:56 pm
Bristol Myers Squibb
Celgene
Nimbus Therapeutics
psoriasis
deucravacitinib
Otezla maker Amgen challenges patient groups to help fix long-lasting psoriasis treatment gaps
Fierce Pharma
Fri, 07/23/21 - 11:05 am
Amgen
Otezla
psoriasis
patients
Galapagos avoids 'complete whiff' as key anti-inflammatory drug fails to beat placebo in midphase trials
Fierce Biotech
Thu, 07/15/21 - 12:25 pm
Galapagos
clinical trials
rheumatoid arthritis
ulcerative colitis
psoriasis
filgotinib
Crowded psoriasis market cuts Lilly’s mirikizumab ambitions
Pharmaforum
Wed, 04/28/21 - 10:24 am
Eli Lilly
psoriasis
mirikizumab
Lilly scraps IL-23 psoriasis program despite phase 3 success, focuses on IBD race against AbbVie, J&J
Fierce Biotech
Tue, 04/27/21 - 10:50 am
Eli Lilly
mirikizumab
psoriasis
Bristol Myers' next-gen immunology med busts Amgen's Otezla in head-to-head study. Is a showdown coming?
Endpoints
Fri, 04/23/21 - 11:12 am
Bristol Myers Squibb
biologics
psoriasis
Amgen
deucravacitinib
Otezla
With new PhIII data in hand, Dermavant lines up topical psoriasis contender for a sprint to the finish line
Endpoints
Fri, 04/23/21 - 11:09 am
Dermavant
psoriasis
tapinarof
clinical trials
Amgen Submits Supplemental NDA for Mild-to-Moderate Psoriasis Drug Otezla
BioSpace
Mon, 02/22/21 - 11:49 pm
Amgen
Otezla
FDA
psoriasis
Dermavant shows deepening effects of tapinarof on psoriasis ahead of FDA filing
Fierce Biotech
Thu, 02/18/21 - 10:57 am
Dermavant Sciences
psoriasis
tapinarof
clinical trials
DiCE gets its 'library' card ready as it speeds development of DNA database-derived molecules with more investor cash
Endpoints
Fri, 01/8/21 - 09:45 am
DiCE Molecules
psoriasis
small molecule drugs
Novartis puts spokesceleb Cyndi Lauper in host chair for life-with-psoriasis podcast
Fierce Pharma
Sat, 08/29/20 - 11:38 pm
Novartis
podcasts
psoriasis
celebrity endorsements
Cosentyx
Phase 3 wins put Dermavant closer to filing Otezla rival tapinarof
Pharmaforum
Thu, 08/27/20 - 11:04 am
Dermavant
GSK
tapinarof
psoriasis
Otezla
clinical trials
AbbVie's Skyrizi stands to gain as docs move away from older psoriasis meds—Amgen's Otezla included
Fierce Pharma
Tue, 08/25/20 - 11:12 am
psoriasis
AbbVie
Skyrizi
Amgen
Celgene
Otezla
Amgen's psoriasis pill Otezla thrives amid pandemic against injectable rivals
Fierce Pharma
Wed, 07/29/20 - 12:31 pm
Otzela
Celgene
Amgen
psoriasis
COVID-19
UCB touts another psoriasis win, this time over Cosentyx, as they look to break into packed market
Endpoints
Fri, 07/24/20 - 11:17 am
UCB Pharma
psoriasis
bimekizumab
Cosentyx
Leo Pharma offloads a psoriasis asset as their Dupixent rival heads to the FDA
Endpoints
Tue, 07/21/20 - 10:27 am
LEO Pharma
psoriasis
Sanofi
Dupixent
LP0058
Eli Lilly’s Mirikizumab Hits the Mark in Phase III Study, Bests Cosentyx
BioSpace
Sat, 07/18/20 - 12:17 pm
Eli Lilly
psoriasis
mirikizumab
clinical trials
Cosentyx
Novartis
Amgen's Enbrel Patents to Be Upheld Through 2029
Motley Fool
Thu, 07/2/20 - 12:15 am
psoriasis
rheumatoid arthritis
Enbrel
Novartis
biosimilars
patents
UCB’s growth driver squares up against the competition
EP Vantage
Thu, 06/11/20 - 12:20 pm
UCB Pharma
bimekizumab
psoriasis
clinical trials
Novartis
Cosentyx
Pages
« first
‹ previous
1
2
3
4
5
6
7
8
9
…
next ›
last »